IP Verse

Compositions For The Treatment Of Gastrointestinal Inflammation - EP3354276B1

PatentPatent Analysis

EP3354276

MERITAGE PHARMA
Application Number
EP17210162A
Filing Date
Nov 12, 2008
Status
Revoked
Apr 15, 2022
Grant Date
Jan 1, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3574914B1
EP2585075B8
EP2214679B1

Bibliography

The patent EP3354276B1 was granted to Meritage Pharma on Jan 1, 2020 following the initial filing on Nov 12, 2008 under the application number EP17210162A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AECHTEROct 1, 2020ADMISSIBLE
DR FALK PHARMASep 23, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents